MedTrace Logo

Epidemiological Study of the Covid-19 Presto Test - The "COVIDOR" Study

NCT04387968 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3228

Last updated 2021-10-05

No results posted yet for this study

Summary

The "COVIDOR" epidemiological study. Our study would be the first at the community level in Orleans Métropole, aiming to determine the link between a positive IgM level on the serological test and a healthy carrier of covid-19 in agents in contact with the public. It would provide epidemiological surveillance of anti-covid-19 immunity in the community

Conditions

  • Coronavirus Infection

Interventions

DIAGNOSTIC_TEST

Covid-19 presto test

Use an auto-test in 15 minutes get the results about covid-19 anticorps

Sponsors & Collaborators

  • François Rabelais University

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • University Hospital, Paris

    collaborator OTHER

  • Raphael Serreau

    lead OTHER

Principal Investigators

  • Dr Raphael SERREAU, MD, PhD · Orleans Metropole

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-24
Primary Completion
2021-07-13
Completion
2021-10-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04387968 on ClinicalTrials.gov